Answers are grounded in this paper and cite their sources.
Background Nanoliposomal irinotecan (nal-IRI) combined with levofolinate (l-LV) and fluorouracil (5-FU) is an effective second-line treatment for unresectable pancreatic cancer. The approved dosing schedule comprises sequential administration of premedication, nal-IRI (90 min), and l-LV (120 min), followed by 5-FU (46 h). This study evaluated the feasibility of parallel administration to shorten total infusion time by comparing parallel and sequential administration schedules. Methods This retrospective study included patients who received the nal-IRI regimen between June 2020 and December 2024. Patients were divided into two groups according to the administration schedule: sequential administration (June to October 2020, n = 13) and parallel administration (November 2020 to December 2024, n = 98). The primary endpoint was the incidence of grade ≥ 3 neutropenia within 90 d of treatment initiation. Results Grade ≥ 3 neutropenia occurred in 15.4% of patients in the sequential‑administration group and 39.8% in the parallel‑administration group (unadjusted odds ratio, 3.64; 95% confidence interval, 0.76–17.30; P = 0.13). The incidence in the first cycle was 7.7% and 8.2% between the groups ( P = 1.00). The incidences of other grade ≥ 3 and all-grade adverse events also did not differ significantly between the groups. The incidences of febrile neutropenia and fever did not differ significantly between the groups (febrile neutropenia: 7.7% vs. 7.1%, P = 1.00; fever: 46.2% vs. 25.5%, P = 0.18). The parallel-administration group had a disease control rate of 48.8%, which did not differ significantly from that of the sequential-administration group (33.3%; P = 0.37). Parallel administration reduced the daily bed occupancy time by approximately 150 min. Conclusions Parallel administration of nal-IRI and l-LV may be operationally feasible for improving resource efficiency in outpatient chemotherapy units; however, its comparative safety relative to sequential administration remains uncertain because of imprecision in the effect estimates.
No takes yet. Share an insight, caveat, or question.
Sakamoto et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: